Antihyperglycemic effect of ginsenoside Rh2 by inducing islet β-cell regeneration in mice

Hormone and Metabolic Research

Volumn 44, Issue 1, 2012, Pages 33-40

  Wang, Y ^a,b   Wang, H ^b   Liu, Y ^c   Li, C ^a   Qi, P ^b   Bao, J ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c 91388 Military Hospital   (China)

Author keywords

Akt Foxo1 PDX 1 signaling pathway; cyclin D Cdk4 complex; ginsenoside Rh2 (GS Rh2); islet regeneration; partial pancreatectomy

Indexed keywords

CELL CYCLE PROTEIN; GINSENOSIDE RH 2; INSULIN; PROTEIN KINASE B; SODIUM CHLORIDE; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR PDX 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; C57BL 6 MOUSE; CELL GROWTH; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MEGADOSE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL HYPERPLASIA; PANCREAS RESECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHAM PROCEDURE;

ANIMALS; CELL DEATH; CELL PROLIFERATION; CYCLIN D; GINSENOSIDES; GLUCOSE; HOMEODOMAIN PROTEINS; HOMEOSTASIS; HYPERPLASIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; MICE; MICE, INBRED C57BL; REGENERATION; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; UP-REGULATION;

MUS;

EID: 84855272692     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0031-1295416     Document Type: Article

References (36)

1. Bonner-Weir S, Sharma A. Are there pancreatic progenitor cells from which new islets form after birth? Nat Clin Pract Endocrinol Metab: 2006; 2 240 241
2. De Leon D D, Deng S, Madani R, Ahima R S, Drucker D J, Stoffers D A. Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy. Diabetes: 2003; 52 365 371 (Pubitemid 36173191)
3. Tews D, Lehr S, Hartwig S, Osmers A, Paslack W, Eckel J. Anti-apoptotic action of exendin-4 in INS-1 beta cells: comparative protein pattern analysis of isolated mitochondria. Horm Metab Res: 2009; 41 294 301
4. Kawasaki Y, Harashima S, Sasaki M, Mukai E, Nakamura Y, Harada N, Toyoda K, Hamasaki A, Yamane S, Yamada C, Yamada Y, Seino Y, Inagaki N. Exendin-4 protects pancreatic beta cells from the cytotoxic effect of rapamycin by inhibiting JNK and p38 phosphorylation. Horm Metab Res: 2010; 42 311 317
5. Attele A S, Zhou Y P, Xie J T, Wu J A, Zhang L, Dey L, Pugh W, Rue P A, Polonsky K S, Yuan C S. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes: 2002; 51 1851 1858 (Pubitemid 34564298)
6. Xie J T, Wu J A, Mehendale S, Aung H H, Yuan C S. Anti-hyperglycemic effect of the polysaccharides fraction from American ginseng berry extract in ob/ob mice. Phytomedicine: 2004; 11 182 187 (Pubitemid 38314060)
7. Reeds D N, Patterson B W, Okunade A, Holloszy J O, Polonsky K S, Klein S. Ginseng and ginsenoside Re do not improve beta-cell function or insulin sensitivity in overweight and obese subjects with impaired glucose tolerance or diabetes. Diabetes Care: 2011; 34 1071 1076
8. Lee W K, Kao S T, Liu I M, Cheng J T. Increase of insulin secretion by ginsenoside Rh2 to lower plasma glucose in Wistar rats. Clin Exp Pharmacol Physiol: 2006; 33 27 32
9. Lai D M, Tu Y K, Liu I M, Chen P F, Cheng J T. Mediation of beta-endorphin by ginsenoside Rh2 to lower plasma glucose in streptozotocin-induced diabetic rats. Planta Med: 2006; 72 9 13
10. Lee W K, Kao S T, Liu I M, Cheng J T. Ginsenoside Rh2 is one of the active principles of Panax ginseng root to improve insulin sensitivity in fructose-rich chow-fed rats. Horm Metab Res: 2007; 39 347 354
11. Alonso L C, Yokoe T, Zhang P, Scott D K, Kim S K, ODonnell C P, Garcia-Ocana A. Glucose infusion in mice: a new model to induce beta-cell replication. Diabetes: 2007; 56 1792 1801 (Pubitemid 47025447)
12. Georgia S, Hinault C, Kawamori D, Hu J, Meyer J, Kanji M, Bhushan A, Kulkarni R N. Cyclin D2 is essential for the compensatory beta-cell hyperplastic response to insulin resistance in rodents. Diabetes: 2010; 59 987 996
13. Matsushime H, Quelle D E, Shurtleff S A, Shibuya M, Sherr C J, Kato J Y. D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol: 1994; 14 2066 2076 (Pubitemid 24074604)
14. Fatrai S, Elghazi L, Balcazar N, Cras-Meneur C, Krits I, Kiyokawa H, Bernal-Mizrachi E. Akt induces beta-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity. Diabetes: 2006; 55 318 325 (Pubitemid 43343259)
15. Park S Y, Bell GI. Noninvasive monitoring of changes in pancreatic beta-cell mass by bioluminescent imaging in MIP-luc transgenic mice. Horm Metab Res: 2009; 41 1 4
16. Jung H S, Ahn Y R, Oh S H, Kim Y S, No H, Lee M K, Kim K W. Enhancement of beta-cell regeneration by islet transplantation after partial pancreatectomy in mice. Transplantation: 2009; 88 354 359
17. Kulkarni R N, Jhala U S, Winnay J N, Krajewski S, Montminy M, Kahn C R. PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance. J Clin Invest: 2004; 114 828 836 (Pubitemid 39578742)
18. Brazil D P, Yang Z Z, Hemmings B A. Advances in protein kinase B signaling. AKTion on multiple fronts. Trends Biochem Sci: 2004; 29 233 242 (Pubitemid 38591317)
19. Kim A H, Khursigara G, Sun X, Franke T F, Chao M V. Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol Cell Biol: 2001; 21 893 901 (Pubitemid 32104737)
20. Tuttle R L, Gill N S, Pugh W, Lee J P, Koeberlein B, Furth E E, Polonsky K S, Naji A, Birnbaum M J. Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nat Med: 2001; 7 1133 1137 (Pubitemid 33010022)
21. Rao P, Roccisana J, Takane K K, Bottino R, Zhao A, Trucco M, Garcia-Ocana A. Gene transfer of constitutively active Akt markedly improves human islet transplant outcomes in diabetic severe combined immunodeficient mice. Diabetes: 2005; 54 1664 1675 (Pubitemid 40770756)
22. Kitamura T, Nakae J, Kitamura Y, Kido Y, Biggs W H 3rd, Wright C V, White M F, Arden K C, Accili D. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J Clin Invest: 2002; 110 1839 1847 (Pubitemid 36076491)
23. Aoki M, Jiang H, Vogt P K. Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins. Proc Natl Acad Sci USA: 2004; 101 13613 13617 (Pubitemid 39238451)
24. Ziegler P, Teller S, Ha N H, Giese B, Fraunholz M, Walther R. Phosphoproteomic identification of a PDX-1/14-3-3epsilon interaction in pancreatic beta cells. Horm Metab Res: 2011; 43 165 170
25. Ramaswamy S, Nakamura N, Sansal I, Bergeron L, Sellers W R. A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell: 2002; 2 81 91 (Pubitemid 41043990)
26. Georgia S, Hinault C, Kawamori D, Hu J, Meyer J, Kanji M, Bhushan A, Kulkarni R N. Cyclin D2 is essential for the compensatory beta-cell hyperplastic response to insulin resistance in rodents. Diabetes: 2010; 59 987 996
27. Rane S G, Dubus P, Mettus R V, Galbreath E J, Boden G, Reddy E P, Barbacid M. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat Genet: 1999; 22 44 52
28. Xie J T, Wang C Z, Wang A B, Wu J, Basila D, Yuan C S. Antihyperglycemic effects of total ginsenosides from leaves and stem of Panax ginseng. Acta Pharmacol Sin: 2005; 26 1104 1110 (Pubitemid 41296950)
29. Park S, Ahn I S, Kwon D Y, Ko B S, Jun W K. Ginsenosides Rb1 and Rg1 suppress triglyceride accumulation in 3T3-L1 adipocytes and enhance beta-cell insulin secretion and viability in Min6 cells via PKA-dependent pathways. Biosci Biotechnol Biochem: 2008; 72 2815 2823
30. Hwang J T, Lee M S, Kim H J, Sung M J, Kim H Y, Kim M S, Kwon D Y. Antiobesity effect of ginsenoside Rg3 involves the AMPK and PPAR-gamma signal pathways. Phytother Res: 2009; 23 262 266
31. Lee O H, Lee H H, Kim J H, Lee B Y. Effect of ginsenosides Rg3 and Re on glucose transport in mature 3T3-L1 adipocytes. Phytother Res: 2011; 25 768 773
32. Xiong Y, Shen L, Liu K J, Tso P, Xiong Y, Wang G, Woods S C, Liu M. Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats. Diabetes: 2010; 59 2505 2512
33. Shang W, Yang Y, Jiang B, Jin H, Zhou L, Liu S, Chen M. Ginsenoside Rb1 promotes adipogenesis in 3T3-L1 cells by enhancing PPARgamma2 and C/EBPalpha gene expression. Life Sci: 2007; 80 618 625 (Pubitemid 46074052)
34. Lee K T, Jung T W, Lee H J, Kim S G, Shin Y S, Whang W K. The antidiabetic effect of ginsenoside Rb2 via activation of AMPK. Arch Pharm Res: 2011; 34 1201 1208
35. Xie J T, Mehendale S R, Li X, Quigg R, Wang X, Wang C Z, Wu J A, Aung H H. P AR Bell G I, Yuan C S. Anti-diabetic effect of ginsenoside Re in ob/ob mice. Biochim Biophys Acta: 2005; 1740 319 325 (Pubitemid 40804743)
36. Zhang Z, Li X, Lv W, Yang Y, Gao H, Yang J, Shen Y, Ning G. Ginsenoside Re reduces insulin resistance through inhibition of c-Jun NH2-terminal kinase and nuclear factor-kappaB. Mol Endocrinol: 2008; 22 186 195